Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further.
作者信息
Zariffa Névine, Haggstrom Jonas, Rockhold Frank
机构信息
NMD Group LLC, Bala Cynwyd, USA.
Cytel Corporation, Waltham, USA.
出版信息
Ther Innov Regul Sci. 2021 May;55(3):558-560. doi: 10.1007/s43441-020-00250-z. Epub 2020 Dec 24.
Abstract
摘要
相似文献
1
Open Science to Address COVID-19: Sharing Data to Make Our Research Investment Go Further.开放科学应对新冠疫情：共享数据，让我们的研究投入更具成效。
Ther Innov Regul Sci. 2021 May;55(3):558-560. doi: 10.1007/s43441-020-00250-z. Epub 2020 Dec 24.
2
COVID-19 and the research scholarship ecosystem: help!COVID-19 与科研学术生态系统：救命！
J Clin Epidemiol. 2021 Sep;137:133-136. doi: 10.1016/j.jclinepi.2021.03.032. Epub 2021 Apr 21.
3
COVID-19 and the boundaries of open science and innovation: Lessons of traceability from genomic data sharing and biosecurity.新冠病毒大流行与开放科学和创新的界限：从基因组数据共享和生物安全角度看可追溯性的教训。
EMBO Rep. 2020 Nov 5;21(11):e51773. doi: 10.15252/embr.202051773. Epub 2020 Oct 21.
4
Using Open Source, Open Data, and Civic Technology to Address the COVID-19 Pandemic and Infodemic.利用开源、开放数据和公民技术应对新冠疫情和信息疫情。
Yearb Med Inform. 2021 Aug;30(1):38-43. doi: 10.1055/s-0041-1726488. Epub 2021 Apr 21.
5
Tackling the politicisation of COVID-19 data reporting through open access data sharing.通过开放获取数据共享应对新冠疫情数据报告的政治化问题。
Lancet Infect Dis. 2022 Dec;22(12):1660-1661. doi: 10.1016/S1473-3099(22)00505-9. Epub 2022 Aug 31.
6
Collaboration in times of COVID-19: the urgent need for open-data sharing in Latin America.新冠疫情期间的合作：拉丁美洲对开放数据共享的迫切需求。
BMJ Health Care Inform. 2020 Jul;27(1). doi: 10.1136/bmjhci-2020-100159.
7
A need for open public data standards and sharing in light of COVID-19.鉴于新冠疫情，对开放公共数据标准和共享的需求。
Lancet Infect Dis. 2021 Apr;21(4):e80. doi: 10.1016/S1473-3099(20)30635-6. Epub 2020 Aug 10.
8
Open science approaches to COVID-19.应对新冠疫情的开放科学方法。
F1000Res. 2020 Aug 25;9:1043. doi: 10.12688/f1000research.26084.1. eCollection 2020.
9
Delivering on NIH data sharing requirements: avoiding Open Data in Appearance Only.兑现 NIH 数据共享要求：避免仅做“开放数据”的表面功夫。
BMJ Health Care Inform. 2023 Jun;30(1). doi: 10.1136/bmjhci-2023-100771.
10
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.国家 COVID 队列协作组织（N3C）：原理、设计、基础设施和部署。
J Am Med Inform Assoc. 2021 Mar 1;28(3):427-443. doi: 10.1093/jamia/ocaa196.
引用本文的文献
1
Shooting the moon: the National Cancer Institute's implementation framework for data sharing policies.“摘星揽月”：美国国立癌症研究所的数据共享政策实施框架
Nat Med. 2024 Aug;30(8):2117-2120. doi: 10.1038/s41591-024-02950-7.
2
From policy to practice: Lessons learned from an open science funding initiative.从政策到实践：开放科学资助计划的经验教训。
PLoS Comput Biol. 2023 Dec 7;19(12):e1011626. doi: 10.1371/journal.pcbi.1011626. eCollection 2023 Dec.
3
Totality of evidence of the effectiveness of repurposed therapies for COVID-19: Can we use real-world studies alongside randomized controlled trials?重新利用疗法治疗 COVID-19 的有效性的证据全貌：我们能否在随机对照试验的基础上同时使用真实世界研究？
Clin Transl Sci. 2023 Oct;16(10):1842-1855. doi: 10.1111/cts.13591. Epub 2023 Aug 28.
4
Digital Research Environment(DRE)-enabled Artificial Intelligence (AI) to facilitate early stage drug development.借助数字研究环境（DRE）的人工智能（AI）促进药物早期研发。
Front Pharmacol. 2023 Mar 24;14:1115356. doi: 10.3389/fphar.2023.1115356. eCollection 2023.
5
Crowdsourcing and global collaboration during COVID-19 pandemic: A silver lining.新冠疫情期间的众包与全球合作：一线希望。
J Surg Oncol. 2021 Apr;123(5):1204-1205. doi: 10.1002/jso.26417. Epub 2021 Feb 9.
本文引用的文献
1
Open science: The open clinical trials data journey.开放科学：开放临床试验数据之旅。
Clin Trials. 2019 Oct;16(5):539-546. doi: 10.1177/1740774519865512. Epub 2019 Jul 26.
2
Clinical Trial Participants' Views of the Risks and Benefits of Data Sharing.临床试验参与者对数据共享风险和收益的看法。
N Engl J Med. 2018 Jun 7;378(23):2202-2211. doi: 10.1056/NEJMsa1713258.
Zotero 插件